Market Cap 216.99B P/E 34.40 EPS this Y 19.50% Ern Qtrly Grth 121.40%
Income 6.35B Forward P/E 26.32 EPS next Y 6.40% 50D Avg Chg 5.00%
Sales 40.23B PEG 2.12 EPS past 5Y 8.16% 200D Avg Chg 3.00%
Dividend 1.00% Price/Book 6.47 EPS next 5Y 12.84% 52W High Chg -5.00%
Recommedations 1.80 Quick Ratio - Shares Outstanding 1.78B 52W Low Chg 24.00%
Insider Own 0.73% ROA - Shares Float 1.76B Beta 0.68
Inst Own 75.87% ROE - Shares Shorted/Prior 11.62M/14.01M Price 122.12
Gross Margin 56.98% Profit Margin 15.85% Avg. Volume 6,239,956 Target Price 125.95
Oper. Margin 20.02% Earnings Date Oct 19 Volume 3,688,085 Change 0.99%
Abbott Laboratories News
08/03/21 Top Analyst Reports for Alphabet, Abbott & T-Mobile
08/03/21 Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart
08/02/21 Abbott Labs to pay $160 mln over kickbacks, false diabetes claims to Medicare
08/02/21 Abbott Labs to pay $160 million over kickbacks, false diabetes claims to Medicare
08/02/21 Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
07/30/21 Abbott Launches Latest Insertable Cardiac Monitor For Irregular Heart Rhythms
07/30/21 Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital
07/29/21 10 Medical Technology Stocks to Buy
07/29/21 New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
07/29/21 3 Dividend Stocks Safe Enough to Bet the Farm On
07/28/21 Anxious About a Market Crash? Start Doing These 3 Things Right Now
07/27/21 Worries About the Delta Variant Could Be Overdone Based on Clues From These Healthcare Giants
07/23/21 10 Best Dividend Aristocrats to Buy According to Hedge Funds
07/23/21 Building Trust and Improving Care in Underserved Communities
07/22/21 Abbott Hits The Skids As Covid Testing Demand Falls Off Despite Quarterly Beat
07/22/21 Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
07/22/21 Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop
07/22/21 Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance
07/22/21 Abbott (ABT) Surpasses Q2 Earnings and Revenue Estimates

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

ABT Chatroom

User Image bryantvsu Posted - 59 minutes ago

$ABT $126 soon

User Image WallStFacts Posted - 2 hours ago

$ABT: Here is the forecast and amrket data for Abbott Laboratories https://wallstreetfacts.com/2021/08/03/abt-here-is-the-forecast-and-amrket-data-for-abbott-laboratories-2/?utm_source=dlvr.it&utm_medium=stocktwits

User Image kingddong Posted - 2 hours ago

$ABT https://m.startribune.com/fired-twin-cities-sales-rep-sues-abbott-labs-claiming-gender-age-discrimination/600084127/?clmob=y&c=n

User Image WallStreetFriend Posted - 3 hours ago

Your daily News digest for Abbott Laboratories $ABT https://wsfriend.com/daily/news/ABT/2021-08-03/

User Image inchartitrust Posted - 4 hours ago

$ABT $200 next year, likely. Lovely.

User Image inchartitrust Posted - 4 hours ago

$ABT the convergent point is about $220

User Image BlueStone19 Posted - 7 hours ago

$ABT $1.20

User Image WSFacts Posted - 8 hours ago

$ABT: Have you seen the latest forecast & market data for Abbott Laboratories https://wallstreetfacts.com/2021/08/03/abt-have-you-seen-the-latest-forecast-market-data-for-abbott-laboratories-2/?utm_source=dlvr.it&utm_medium=stocktwits

User Image QuiverQuant Posted - 8 hours ago

Today, $ABT had an off-exchange short-sale volume of 424 thousand shares. See more off-exchange transaction data at https://www.quiverquant.com/offexchange/

User Image Eyore Posted - 9 hours ago

$WMT $ABT Added some commons Trying to buy more stocks in companies that aren't going to move 10 percent in a day I am 🧓

User Image cctranscripts Posted - 9 hours ago

Abbott Laboratories insider just disposed of 1,245 shares https://www.conferencecalltranscripts.com/summary/?id=9724588 $ABT

User Image fla Posted - 9 hours ago

$ABT [15s. delayed] filed SEC form 4: EXECUTIVE VICE PRESIDENT Moreland Mary K: Delivered securities 1,245 of Common shares without par v https://s.flashalert.me/z9gi4

User Image Newsfilter Posted - 9 hours ago

$ABT $150,620.10 of shares sold by Moreland Mary K (EXECUTIVE VICE PRESIDENT), reported in a new form 4 filed with the SEC https://newsfilter.io/a/6f13f29aa9a0a2750eb96b9cb27ff82d

User Image Newsfilter Posted - 10 hours ago

$ABT Abbott Laboratories Inc was awarded a new government contract "iSTAT Analyzer Maintenance Service for Tripler Army Medical Center, Hawaii", total contract value: $56,547 https://newsfilter.io/a/a9444cb29af1c84b0f5964047cbdd1d1

User Image SweepCast Posted - 10 hours ago

SweepCast alerted: $ABT with Unusual Options Activity Alerted on $125 CALL Expiring: 09-17-2021 worth 58K🐂 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=ABT&name=CALL&strike=$125&type=SWEEP&pre=$58K&exp=09-17-2021 🎯 |

User Image truth305 Posted - 11 hours ago

$ABT finish strong 💪

User Image truth305 Posted - 11 hours ago

$ABT if only u can stay running 🏃‍♀️

User Image inchartitrust Posted - 11 hours ago

$ABT vs $FTNT abt

User Image usiv Posted - 12 hours ago

$ABT squeeze

User Image WSFacts Posted - 14 hours ago

$ABT: Investors are talking about the forecast for Abbott Laboratories https://wallstreetfacts.com/2021/08/03/abt-investors-are-talking-about-the-forecast-for-abbott-laboratories-12/?utm_source=dlvr.it&utm_medium=stocktwits

User Image LiquidAlerts Posted - 14 hours ago

LiquidTheta® Trade Alert (Delayed/Actionable) Ticker: $ABT Buy: Jan 21 2022 $125.00 Calls Entry Price: $5.35- $5.50 TP1: $6.42 TP2: $7.22 TP3: $8.02 Stop Loss: $4.63 (Optional) Highly Profitable Options Signals Delivered to Your Inbox

User Image EJM2 Posted - 15 hours ago

$ABT This chart is what keeps me holding forever.

User Image BlueStone19 Posted - 16 hours ago

$ABT keep going!!!!

User Image briefingcom Posted - 16 hours ago

$ABT receives FDA clearance for its imaging technology using artificial intelligence for vessels in the heart https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20210803090315ABT

User Image usiv Posted - 17 hours ago

$ABT yeah I like that

User Image Newsfilter Posted - 17 hours ago

$ABT Abbott gets FDA clearance for Ultreon powered OCT imaging platform https://newsfilter.io/a/80b59bbf3a4bbbf5ee68561048dcc393

User Image STCKPRO Posted - 18 hours ago

$ABT NEW ARTICLE : Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart https://www.stck.pro/news/ABT/14726984

User Image Stonkmoon Posted - 18 hours ago

$ABT 2021-08-03 09:00 ET Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart https://stonkmoon.com/news/ABT/7b7353f9c82c5bd3fa37a47eb9278a04

User Image Quantisnow Posted - 18 hours ago

$ABT 📰 Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart https://quantisnow.com/insight/1595554?s=s 30s delayed.

User Image Stock_Titan Posted - 18 hours ago

$ABT Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart https://www.stocktitan.net/news/ABT/abbott-receives-fda-clearance-for-its-imaging-technology-using-7na73mcyjsll.html

Analyst Ratings
Morgan Stanley Overweight Jul 23, 21
Credit Suisse Outperform Jul 23, 21
Raymond James Outperform Jul 23, 21
SVB Leerink Market Perform Jul 20, 21
Wells Fargo Overweight Jul 12, 21
Credit Suisse Outperform Jun 2, 21
BTIG Buy Jun 2, 21
Morgan Stanley Overweight Jun 2, 21
Raymond James Outperform Jun 2, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
Watkin Jared SENIOR VICE P.. SENIOR VICE PRESIDENT May 4, 7:07 PM Option 52.17 85,043 4,436,693 144,826
Watkin Jared SENIOR VICE P.. SENIOR VICE PRESIDENT May 4, 7:07 PM Sell 119.95 94,576 11,344,391 59,783
Salvadori Daniel Gesua Sive EXECUTIVE VIC.. EXECUTIVE VICE PRESIDENT Mar 2, 7:54 PM Sell 120.61 1,664 200,695 107,430
DALE MICHAEL D SENIOR VICE P.. SENIOR VICE PRESIDENT Mar 2, 7:13 PM Sell 120.61 1,475 177,900 39,691
Ahlberg Gregory A SENIOR VICE P.. SENIOR VICE PRESIDENT Mar 2, 6:49 PM Sell 120.61 1,052 126,882 14,045
Moreland Mary K EXECUTIVE VIC.. EXECUTIVE VICE PRESIDENT Feb 18, 5:57 PM Sell 128.49 505 64,887 63,373
Funck Robert E EXECUTIVE VIC.. EXECUTIVE VICE PRESIDENT Feb 4, 6:56 PM Option 39.12 31,325 1,225,434 193,542
MANNING JOSEPH J SENIOR VICE P.. SENIOR VICE PRESIDENT Feb 3, 7:20 PM Option 38.4 18,750 720,000 81,561
MANNING JOSEPH J SENIOR VICE P.. SENIOR VICE PRESIDENT Feb 3, 7:20 PM Sell 122.91 21,880 2,689,271 59,681
NOVAKOVIC PHEBE N Director Director Dec 8, 5:58 PM Option 33.16 14,681 486,822 45,794
NOVAKOVIC PHEBE N Director Director Dec 8, 5:58 PM Sell 107.28 4,790 513,871 41,004
Funck Robert E Executive Vic.. Executive Vice President & CFO Oct 28, 6:33 PM Option 38.4 83,333 3,199,987 265,550
Funck Robert E Executive Vic.. Executive Vice President & CFO Oct 28, 6:33 PM Sell 108.83 83,333 9,069,130 182,217